The amelioration of cartilage degeneration by ADAMTS-5 inhibitor delivered in a hyaluronic acid hydrogel

Biomaterials

Volumn 35, Issue 9, 2014, Pages 2827-2836

  Chen, Pengfei ^a,b   Zhu, Shouan ^a,b   Wang, Yanyan ^a,b   Mu, Qin ^a,b   Wu, Yan ^a,b   Xia, Qingqing ^a,b   Zhang, Xiaolei ^a,b   Sun, Heng ^a,b   Tao, Jiadong ^a,b   Hu, Hu ^a   Lu, Ping ^a,b   Ouyang, Hongwei ^a,b  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Zhejiang Provincial Key Laboratory of Tissue Engineering and Regenerative Medicine   (China)

Author keywords

ADAMTS 5; Hydrogel; Osteoarthritis; Osteochondral defect

Indexed keywords

ADAMTS-5; HYDROGEL; OSTEOARTHRITIS; OSTEOCHONDRAL DEFECT;

ADAM PROTEINS; AGGRECANS; ANIMALS; CARTILAGE, ARTICULAR; HUMANS; HYALURONIC ACID; HYDROGEL; INTERLEUKIN-1BETA; OSTEOARTHRITIS; PROTEASE INHIBITORS; PROTEOLYSIS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84895027355     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.12.076     Document Type: Article

References (45)

1. Wang M., Shen J., Jin H., Im H.J., Sandy J., Chen D. Recent progress in understanding molecular mechanisms of cartilage degeneration during osteoarthritis. Ann N Y Acad Sci 2011, 1240:61-69.
2. Santaguida P.L., Hawker G.A., Hudak P.L., Glazier R., Mahomed N.N., Kreder H.J., et al. Patient characteristics affecting the prognosis of total hip and knee joint arthroplasty: a systematic review. Can J Surg 2008, 51(6):428-436.
3. Hollander A.P., Dickinson S.C., Kafienah W. Stem cells and cartilage development: complexities of a simple tissue. Stem Cells 2010, 28(11):1992-1996.
4. Watanabe H., Yamada Y., Kimata K. Roles of aggrecan, a large chondroitin sulfate proteoglycan, in cartilage structure and function. JBiochem 1998, 124(4):687-693.
5. Heinegard D., Saxne T. The role of the cartilage matrix in osteoarthritis. Nat Rev Rheumatol 2011, 7(1):50-56.
6. Glasson S.S., Askew R., Sheppard B., Carito B., Blanchet T., Ma H.L., et al. Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis. Nature 2005, 434(7033):644-648.
7. Stanton H., Rogerson F.M., East C.J., Golub S.B., Lawlor K.E., Meeker C.T., et al. ADAMTS5 is the major aggrecanase in mouse cartilage invivo and invitro. Nature 2005, 434(7033):648-652.
8. Chu X., You H., Yuan X., Zhao W., Li W., Guo X. Protective effect of lentivirus-mediated siRNA targeting ADAMTS-5 on cartilage degradation in a rat model of osteoarthritis. Int J Mol Med 2013, 31(5):1222-1228.
9. Peng L., Duan L., Liu X., Shen M., Li Y., Yan J., et al. Structure-activity study on a series of alpha-glutamic acid scaffold based compounds as new ADAMTS inhibitors. Bioorg Med Chem Lett 2011, 21(15):4457-4461.
10. Atobe M., Maekawara N., Kawanishi M., Suzuki H., Tanaka E., Miyoshi S. Design, synthesis and SAR investigation of thienosultam derivatives as ADAMTS-5 (aggrecanase-2) inhibitors. Bioorg Med Chem Lett 2013, 23(7):2111-2116.
11. Atobe M., Maekawara N., Ishiguro N., Sogame S., Suenaga Y., Kawanishi M., et al. Aseries of thiazole derivatives bearing thiazolidin-4-one as non-competitive ADAMTS-5 (aggrecanase-2) inhibitors. Bioorg Med Chem Lett 2013, 23(7):2106-2110.
12. Nuti E., Santamaria S., Casalini F., Yamamoto K., Marinelli L., La Pietra V., et al. Arylsulfonamide inhibitors of aggrecanases as potential therapeutic agents for osteoarthritis: synthesis and biological evaluation. Eur J Med Chem 2013, 62:379-394.
13. Deng H., O'Keefe H., Davie C.P., Lind K.E., Acharya R.A., Franklin G.J., et al. Discovery of highly potent and selective small molecule ADAMTS-5 inhibitors that inhibit human cartilage degradation via encoded library technology (ELT). JMed Chem 2012, 55(16):7061-7079.
14. Shiozaki M., Maeda K., Miura T., Kotoku M., Yamasaki T., Matsuda I., et al. Discovery of (1S,2R,3R)-2,3-dimethyl-2-phenyl-1-sulfamidocyclopropanecarboxylates: novel and highly selective aggrecanase inhibitors. JMed Chem 2011, 54(8):2839-2863.
15. Maingot L., Leroux F., Landry V., Dumont J., Nagase H., Villoutreix B., et al. New non-hydroxamic ADAMTS-5 inhibitors based on the 1,2,4-triazole-3-thiol scaffold. Bioorg Med Chem Lett 2010, 20(21):6213-6216.
16. Cappelli A., Nannicini C., Valenti S., Giuliani G., Anzini M., Mennuni L., et al. Design, synthesis, and preliminary biological evaluation of pyrrolo[3,4-c]quinolin-1-one and oxoisoindoline derivatives as aggrecanase inhibitors. ChemMedChem 2010, 5(5):739-748.
17. Shiozaki M., Imai H., Maeda K., Miura T., Yasue K., Suma A., et al. Synthesis and SAR of 2-phenyl-1-sulfonylaminocyclopropane carboxylates as ADAMTS-5 (Aggrecanase-2) inhibitors. Bioorg Med Chem Lett 2009, 19(21):6213-6217.
18. Shiozaki M., Maeda K., Miura T., Ogoshi Y., Haas J., Fryer A.M., et al. Novel N-substituted 2-phenyl-1-sulfonylamino-cyclopropane carboxylates as selective ADAMTS-5 (Aggrecanase-2) inhibitors. Bioorg Med Chem Lett 2009, 19(6):1575-1580.
19. Gilbert A.M., Bursavich M.G., Lombardi S., Georgiadis K.E., Reifenberg E., Flannery C.R., et al. N-((8-Hydroxy-5-substituted-quinolin-7-yl)(phenyl)methyl)-2-phenyloxy/amino-acetamide inhibitors of ADAMTS-5 (aggrecanase-2). Bioorg Med Chem Lett 2008, 18(24):6454-6457.
20. Bursavich M.G., Gilbert A.M., Lombardi S., Georgiadis K.E., Reifenberg E., Flannery C.R., et al. 5'-Phenyl-3'H-spiro[indoline-3,2'-[1,3,4]thiadiazol]-2-one inhibitors of ADAMTS-5 (aggrecanase-2). Bioorg Med Chem Lett 2007, 17(20):5630-5633.
21. Gilbert A.M., Bursavich M.G., Lombardi S., Georgiadis K.E., Reifenberg E., Flannery C.R., et al. 5-((1H-pyrazol-4-yl)methylene)-2-thioxothiazolidin-4-one inhibitors of ADAMTS-5. Bioorg Med Chem Lett 2007, 17(5):1189-1192.
22. Bursavich M.G., Gilbert A.M., Lombardi S., Georgiadis K.E., Reifenberg E., Flannery C.R., et al. Synthesis and evaluation of aryl thioxothiazolidinone inhibitors of ADAMTS-5 (aggrecanase-2). Bioorg Med Chem Lett 2007, 17(5):1185-1188.
23. Knudson C.B., Knudson W. Cartilage proteoglycans. Semin Cell Dev Biol 2001, 12(2):69-78.
24. Chen W.Y., Abatangelo G. Functions of hyaluronan in wound repair. Wound Repair Regen 1999, 7(2):79-89.
25. Bian L., Hou C., Tous E., Rai R., Mauck R.L., Burdick J.A. The influence of hyaluronic acid hydrogel crosslinking density and macromolecular diffusivity on human MSC chondrogenesis and hypertrophy. Biomaterials 2013, 34(2):413-421.
26. Jia X., Colombo G., Padera R., Langer R., Kohane D.S. Prolongation of sciatic nerve blockade by in situ cross-linked hyaluronic acid. Biomaterials 2004, 25(19):4797-4804.
27. Xu X., Gurski L.A., Zhang C., Harrington D.A., Farach-Carson M.C., Jia X. Recreating the tumor microenvironment in a bilayer, hyaluronic acid hydrogel construct for the growth of prostate cancer spheroids. Biomaterials 2012, 33(35):9049-9060.
28. Srinivasan P.P., McCoy S.Y., Jha A.K., Yang W., Jia X., Farach-Carson M.C., et al. Injectable perlecan domain 1-hyaluronan microgels potentiate the cartilage repair effect of BMP2 in a murine model of early osteoarthritis. Biomed Mater 2012, 7(2):024109.
29. Aulin C., Bergman K., Jensen-Waern M., Hedenqvist P., Hilborn J., Engstrand T. In situ cross-linkable hyaluronan hydrogel enhances chondrogenesis. JTissue Eng Regen Med 2011, 5(8):e188-e196.
30. Ito T., Yeo Y., Highley C.B., Bellas E., Benitez C.A., Kohane D.S. The prevention of peritoneal adhesions by in situ cross-linking hydrogels of hyaluronic acid and cellulose derivatives. Biomaterials 2007, 28(6):975-983.
31. Bulpitt P., Aeschlimann D. New strategy for chemical modification of hyaluronic acid: preparation of functionalized derivatives and their use in the formation of novel biocompatible hydrogels. JBiomed Mater Res 1999, 47(2):152-169.
32. Farndale R.W., Sayers C.A., Barrett A.J. Adirect spectrophotometric microassay for sulfated glycosaminoglycans in cartilage cultures. Connect Tissue Res 1982, 9(4):247-248.
33. van den Borne M.P., Raijmakers N.J., Vanlauwe J., Victor J., de Jong S.N., Bellemans J., et al. International Cartilage Repair Society (ICRS) and Oswestry macroscopic cartilage evaluation scores validated for use in autologous chondrocyte implantation (ACI) and microfracture. Osteoarthr Cartil 2007, 15(12):1397-1402.
34. Mainil-Varlet P., Aigner T., Brittberg M., Bullough P., Hollander A., Hunziker E., et al. Histological assessment of cartilage repair: a report by the Histology Endpoint Committee of the International Cartilage Repair Society (ICRS). JBone Jt Surg Am 2003, 85-A(Suppl.2):45-57.
35. Pritzker K.P., Gay S., Jimenez S.A., Ostergaard K., Pelletier J.P., Revell P.A., et al. Osteoarthritis cartilage histopathology: grading and staging. Osteoarthr Cartil 2006, 14(1):13-29.
36. Wang D.A., Varghese S., Sharma B., Strehin I., Fermanian S., Gorham J., et al. Multifunctional chondroitin sulphate for cartilage tissue-biomaterial integration. Nat Mater 2007, 6(5):385-392.
37. Antunes J.C., Oliveira J.M., Reis R.L., Soria J.M., Gomez-Ribelles J.L., Mano J.F. Novel poly(L-lactic acid)/hyaluronic acid macroporous hybrid scaffolds: characterization and assessment of cytotoxicity. JBiomed Mater Res A 2010, 94(3):856-869.
38. Yeo Y., Highley C.B., Bellas E., Ito T., Marini R., Langer R., et al. In situ cross-linkable hyaluronic acid hydrogels prevent post-operative abdominal adhesions in a rabbit model. Biomaterials 2006, 27(27):4698-4705.
39. Tan H., Ramirez C.M., Miljkovic N., Li H., Rubin J.P., Marra K.G. Thermosensitive injectable hyaluronic acid hydrogel for adipose tissue engineering. Biomaterials 2009, 30(36):6844-6853.
40. Seki S., Asanuma-Abe Y., Masuda K., Kawaguchi Y., Asanuma K., Muehleman C., et al. Effect of small interference RNA (siRNA) for ADAMTS5 on intervertebral disc degeneration in the rabbit anular needle-puncture model. Arthritis Res Ther 2009, 11(6):R166.
41. Glasson S.S., Askew R., Sheppard B., Carito B.A., Blanchet T., Ma H.L., et al. Characterization of and osteoarthritis susceptibility in ADAMTS-4-knockout mice. Arthritis Rheum 2004, 50(8):2547-2558.
42. Song R.H., Tortorella M.D., Malfait A.M., Alston J.T., Yang Z., Arner E.C., et al. Aggrecan degradation in human articular cartilage explants is mediated by both ADAMTS-4 and ADAMTS-5. Arthritis Rheum 2007, 56(2):575-585.
43. Weiss W.A., Taylor S.S., Shokat K.M. Recognizing and exploiting differences between RNAi and small-molecule inhibitors. Nat Chem Biol 2007, 3(12):739-744.
44. Shen Jie, Wang Meina, Jin Hongting, Sampson Erik, Chen Di Genetic mouse models for osteoarthritis research. Principles of osteoarthritis - its definition, character, derivation and modality-related recognition 2012, InTech. B.M. Rothschild (Ed.).
45. Hudson S.P., Langer R., Fink G.R., Kohane D.S. Injectable in situ cross-linking hydrogels for local antifungal therapy. Biomaterials 2010, 31(6):1444-1452.